BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 26432895)

  • 1. Targeting Anti-Insulin B Cell Receptors Improves Receptor Editing in Type 1 Diabetes-Prone Mice.
    Bonami RH; Thomas JW
    J Immunol; 2015 Nov; 195(10):4730-41. PubMed ID: 26432895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantigen-specific B-cell depletion overcomes failed immune tolerance in type 1 diabetes.
    Henry RA; Kendall PL; Thomas JW
    Diabetes; 2012 Aug; 61(8):2037-44. PubMed ID: 22698916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B lymphocyte "original sin" in the bone marrow enhances islet autoreactivity in type 1 diabetes-prone nonobese diabetic mice.
    Henry-Bonami RA; Williams JM; Rachakonda AB; Karamali M; Kendall PL; Thomas JW
    J Immunol; 2013 Jun; 190(12):5992-6003. PubMed ID: 23677466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversing Tolerance in Isotype Switch-Competent Anti-Insulin B Lymphocytes.
    Williams JM; Bonami RH; Hulbert C; Thomas JW
    J Immunol; 2015 Aug; 195(3):853-64. PubMed ID: 26109644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficiency of B cell receptor (BCR) editing is dependent on BCR light chain rearrangement status.
    Yachimovich N; Mostoslavsky G; Yarkoni Y; Verbovetski I; Eilat D
    Eur J Immunol; 2002 Apr; 32(4):1164-74. PubMed ID: 11932924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B cell deletion, anergy, and receptor editing in "knock in" mice targeted with a germline-encoded or somatically mutated anti-DNA heavy chain.
    Pewzner-Jung Y; Friedmann D; Sonoda E; Jung S; Rajewsky K; Eilat D
    J Immunol; 1998 Nov; 161(9):4634-45. PubMed ID: 9794392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble Antigen Arrays for Selective Desensitization of Insulin-Reactive B Cells.
    Leon MA; Wemlinger SM; Larson NR; Ruffalo JK; Sestak JO; Middaugh CR; Cambier JC; Berkland C
    Mol Pharm; 2019 Apr; 16(4):1563-1572. PubMed ID: 30681867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Insulin B Cells Are Poised for Antigen Presentation in Type 1 Diabetes.
    Felton JL; Maseda D; Bonami RH; Hulbert C; Thomas JW
    J Immunol; 2018 Aug; 201(3):861-873. PubMed ID: 29950508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor editing can lead to allelic inclusion and development of B cells that retain antibodies reacting with high avidity autoantigens.
    Liu S; Velez MG; Humann J; Rowland S; Conrad FJ; Halverson R; Torres RM; Pelanda R
    J Immunol; 2005 Oct; 175(8):5067-76. PubMed ID: 16210610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of myelin oligodendrocyte glycoprotein autoreactive transgenic B lymphocytes: receptor editing in vivo after encounter of a self-antigen distinct from myelin oligodendrocyte glycoprotein.
    Litzenburger T; Blüthmann H; Morales P; Pham-Dinh D; Dautigny A; Wekerle H; Iglesias A
    J Immunol; 2000 Nov; 165(9):5360-6. PubMed ID: 11046072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Foxo3 Promotes Apoptosis of B Cell Receptor-Stimulated Immature B Cells, Thus Limiting the Window for Receptor Editing.
    Ottens K; Hinman RM; Barrios E; Skaug B; Davis LS; Li QZ; Castrillon DH; Satterthwaite AB
    J Immunol; 2018 Aug; 201(3):940-949. PubMed ID: 29950509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bruton's Tyrosine Kinase Synergizes with Notch2 To Govern Marginal Zone B Cells in Nonobese Diabetic Mice.
    Case JB; Bonami RH; Nyhoff LE; Steinberg HE; Sullivan AM; Kendall PL
    J Immunol; 2015 Jul; 195(1):61-70. PubMed ID: 26034172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surrogate light chain is required for central and peripheral B-cell tolerance and inhibits anti-DNA antibody production by marginal zone B cells.
    Ren W; Grimsholm O; Bernardi AI; Höök N; Stern A; Cavallini N; Mårtensson IL
    Eur J Immunol; 2015 Apr; 45(4):1228-37. PubMed ID: 25546233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-cell delivered gene therapy for tolerance induction: role of autoantigen-specific B cells.
    Zhang AH; Li X; Onabajo OO; Su Y; Skupsky J; Thomas JW; Scott DW
    J Autoimmun; 2010 Sep; 35(2):107-13. PubMed ID: 20579844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive and negative selection of natural autoreactive B cells.
    Hardy RR; Hayakawa K
    Adv Exp Med Biol; 2012; 750():227-38. PubMed ID: 22903678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CpG DNA stimulates autoreactive immature B cells in the bone marrow.
    Azulay-Debby H; Edry E; Melamed D
    Eur J Immunol; 2007 Jun; 37(6):1463-75. PubMed ID: 17474151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bruton's tyrosine kinase promotes persistence of mature anti-insulin B cells.
    Bonami RH; Sullivan AM; Case JB; Steinberg HE; Hoek KL; Khan WN; Kendall PL
    J Immunol; 2014 Feb; 192(4):1459-70. PubMed ID: 24453243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced diabetes in btk-deficient nonobese diabetic mice and restoration of diabetes with provision of an anti-insulin IgH chain transgene.
    Kendall PL; Moore DJ; Hulbert C; Hoek KL; Khan WN; Thomas JW
    J Immunol; 2009 Nov; 183(10):6403-12. PubMed ID: 19841184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vkappa polymorphisms in NOD mice are spread throughout the entire immunoglobulin kappa locus and are shared by other autoimmune strains.
    Henry RA; Kendall PL; Woodward EJ; Hulbert C; Thomas JW
    Immunogenetics; 2010 Aug; 62(8):507-20. PubMed ID: 20556377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive selection of low affinity autoreactive B cells.
    Kenny JJ; Lustig A; Longo DL
    Curr Top Microbiol Immunol; 2000; 252():39-45. PubMed ID: 11125491
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.